Energy saving mechanism for a Smart Wearable System: monitoring infants during the sleep

In Smart Wearable Systems (SWS), the wearable devices are powered by batteries with very limited energy available. These emergent systems have strong Quality of Service (QoS) requirements, with focus on reliable communication and low power consumption. This is the scope of the Baby Night Watch, a project developed in the context of the European Texas Instruments Innovation Challenge (TIIC) 2015. This Project consists of a monitoring tool for infants, which matches different emergent research fields. SWSs require energy saving mechanism to reduce the energy wasting during wireless communications. A Transmission Power Control (TPC) mechanism that changes its characteristics according to the scenario of operation, is proposed. It uses sensors to determine the position of the infant and, based on that, predicts the current state of the channel. Other TPC algorithms are implemented and their performance are compared with our novel mechanism. The proposed TPC mechanism outperforms the existing ones in terms of the energy saving.Duarte Fernandes and André G. Ferreira are supported by FCT (grant SFRH/BD/92082/2012 and SFRH/BD/91477/2012 respectively). This work was partially funded by FCT within the Project Scope: Pest-OE/EEI/UI0319/2014, and partially funded by -Programa Operacional Factores de Competitividade – COMPETE and National funds through FCT – Fundação para a Ciência e a Tecnologia- under the project UID/CTM/00264

Intracranial EEG fluctuates over months after implanting electrodes in human brain.

OBJECTIVE: Implanting subdural and penetrating electrodes in the brain causes acute trauma and inflammation that affect intracranial electroencephalographic (iEEG) recordings. This behavior and its potential impact on clinical decision-making and algorithms for implanted devices have not been assessed in detail. In this study we aim to characterize the temporal and spatial variability of continuous, prolonged human iEEG recordings. APPROACH: Intracranial electroencephalography from 15 patients with drug-refractory epilepsy, each implanted with 16 subdural electrodes and continuously monitored for an average of 18 months, was included in this study. Time and spectral domain features were computed each day for each channel for the duration of each patient\u27s recording. Metrics to capture post-implantation feature changes and inflexion points were computed on group and individual levels. A linear mixed model was used to characterize transient group-level changes in feature values post-implantation and independent linear models were used to describe individual variability. MAIN RESULTS: A significant decline in features important to seizure detection and prediction algorithms (mean line length, energy, and half-wave), as well as mean power in the Berger and high gamma bands, was observed in many patients over 100 d following implantation. In addition, spatial variability across electrodes declines post-implantation following a similar timeframe. All selected features decreased by 14-50% in the initial 75 d of recording on the group level, and at least one feature demonstrated this pattern in 13 of the 15 patients. Our findings indicate that iEEG signal features demonstrate increased variability following implantation, most notably in the weeks immediately post-implant. SIGNIFICANCE: These findings suggest that conclusions drawn from iEEG, both clinically and for research, should account for spatiotemporal signal variability and that properly assessing the iEEG in patients, depending upon the application, may require extended monitoring

Technology in Parkinson's disease:challenges and opportunities

The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society

Scalable EEG seizure detection on an ultra low power multi-core architecture

none4siEnergy efficient processing architectures represent key elements for wearable and implantable medical devices. Signal processing of neural data is a challenge in new designs of Brain Machine Interfaces (BMI). A highly efficient multi-core platform, designed for ultra low power processing allows the execution of complex algorithms complying with real time requirements. This paper describes the implementation and optimization of a seizure detection algorithm on a multi-core digital integrated circuit designed for energy efficient applications. The proposed architecture is able to implement ultra low power parallel processing seizure detection on 23 electrodes within a power budget of 1 mW, outperforming implementations on commercial MCUs by up to 100 times in terms of performance and up to 80 times in terms of energy efficiency still providing high versatility and scalability, opening the way to the development of efficient implantable and wearable smart systems.openBenatti, S.; Montagna, F.; Rossi, D.; Benini, L.Benatti, S.; Montagna, F.; Rossi, D.; Benini, L

Technology in Parkinson's disease: challenges and opportunities

"The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD."info:eu-repo/semantics/acceptedVersio

Design and Development of Smart Brain-Machine-Brain Interface (SBMIBI) for Deep Brain Stimulation and Other Biomedical Applications

Machine collaboration with the biological body/brain by sending electrical information back and forth is one of the leading research areas in neuro-engineering during the twenty-first century. Hence, Brain-Machine-Brain Interface (BMBI) is a powerful tool for achieving such machine-brain/body collaboration. BMBI generally is a smart device (usually invasive) that can record, store, and analyze neural activities, and generate corresponding responses in the form of electrical pulses to stimulate specific brain regions. The Smart Brain-Machine-Brain-Interface (SBMBI) is a step forward with compared to the traditional BMBI by including smart functions, such as in-electrode local computing capabilities, and availability of cloud connectivity in the system to take the advantage of powerful cloud computation in decision making. In this dissertation work, we designed and developed an innovative form of Smart Brain-Machine-Brain Interface (SBMBI) and studied its feasibility in different biomedical applications. With respect to power management, the SBMBI is a semi-passive platform. The communication module is fully passive—powered by RF harvested energy; whereas, the signal processing core is battery-assisted. The efficiency of the implemented RF energy harvester was measured to be 0.005%. One of potential applications of SBMBI is to configure a Smart Deep-Brain-Stimulator (SDBS) based on the general SBMBI platform. The SDBS consists of brain-implantable smart electrodes and a wireless-connected external controller. The SDBS electrodes operate as completely autonomous electronic implants that are capable of sensing and recording neural activities in real time, performing local processing, and generating arbitrary waveforms for neuro-stimulation. A bidirectional, secure, fully-passive wireless communication backbone was designed and integrated into this smart electrode to maintain contact between the smart electrodes and the controller. The standard EPC-Global protocol has been modified and adopted as the communication protocol in this design. The proposed SDBS, by using a SBMBI platform, was demonstrated and tested through a hardware prototype. Additionally the SBMBI was employed to develop a low-power wireless ECG data acquisition device. This device captures cardiac pulses through a non-invasive magnetic resonance electrode, processes the signal and sends it to the backend computer through the SBMBI interface. Analysis was performed to verify the integrity of received ECG data

Neuromorphic Neuromodulation: Towards the next generation of on-device AI-revolution in electroceuticals

Neuromodulation techniques have emerged as promising approaches for treating a wide range of neurological disorders, precisely delivering electrical stimulation to modulate abnormal neuronal activity. While leveraging the unique capabilities of artificial intelligence (AI) holds immense potential for responsive neurostimulation, it appears as an extremely challenging proposition where real-time (low-latency) processing, low power consumption, and heat constraints are limiting factors. The use of sophisticated AI-driven models for personalized neurostimulation depends on back-telemetry of data to external systems (e.g. cloud-based medical mesosystems and ecosystems). While this can be a solution, integrating continuous learning within implantable neuromodulation devices for several applications, such as seizure prediction in epilepsy, is an open question. We believe neuromorphic architectures hold an outstanding potential to open new avenues for sophisticated on-chip analysis of neural signals and AI-driven personalized treatments. With more than three orders of magnitude reduction in the total data required for data processing and feature extraction, the high power- and memory-efficiency of neuromorphic computing to hardware-firmware co-design can be considered as the solution-in-the-making to resource-constraint implantable neuromodulation systems. This could lead to a new breed of closed-loop responsive and personalised feedback, which we describe as Neuromorphic Neuromodulation. This can empower precise and adaptive modulation strategies by integrating neuromorphic AI as tightly as possible to the site of the sensors and stimulators. This paper presents a perspective on the potential of Neuromorphic Neuromodulation, emphasizing its capacity to revolutionize implantable brain-machine microsystems and significantly improve patient-specificity.Comment: 17 page

Smart Face Masks for Covid-19 Pandemic Management: A Concise Review of Emerging Architectures, Challenges and Future Research Directions

Smart sensing technology has been playing tremendous roles in digital healthcare management over time with great impacts. Lately, smart sensing has awoken the world by the advent of Smart Face Masks (SFM) in the global fight against the deadly Coronavirus (Covid-19) pandemic. In turn, a number of research studies on innovative SFM architectures and designs are emerging. However, there is currently no study that has systematically been conducted to identify and comparatively analyze the emerging architectures and designs of SFMs, their contributions, socio-technological implications, and current challenges. In this paper, we investigate the emerging SFMs in response to Covid-19 pandemic and provide a concise review of their key features and characteristics, design, smart technologies, and architectures. We also highlight and discuss the socio-technological opportunities posed by the use of SFMs and finally present directions for future research. Our findings reveal four key features that can be used to evaluate SFMs to include reusability, self-power generation ability, energy awareness and aerosol filtration efficiency. We discover that SFM has potential for effective use in human tracking, contact tracing, disease detection and diagnosis or in monitoring asymptotic populations in future pandemics. Some SFMs have also been carefully designed to provide comfort and safety when used by patients with other respiratory diseases or comorbidities. However, some identified challenges include standards and quality control, ethical, security and privacy concerns